Notice of general meeting

November 7, 2024 biodexa pharmaceuticals plc (“biodexa” or the “company”) notice of general meeting biodexa pharmaceuticals plc, (nasdaq: bdrx), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs announces a notice of a general meeting to be held at the company's offices, 1 caspian point, caspian way, cardiff, cf10 4dq on 22 november 2024 at 13:00 gmt was posted to shareholders yesterday. the board of directors is proposing two resolutions: ordinary resolution       1.
GM Ratings Summary
GM Quant Ranking